Peringkat dalam Saham
#6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Harga Saham
$14.30
Terakhir disinkronkan: 2023-06-29
Kapitalisasi Pasar
$1.81B
Perubahan (1 hari)
-2.81%
Perubahan (1 tahun)
0.00%
Perdagangan BELLUS Health Inc. (BLU)
Harga BLU dengan kapitalisasi pasar B
Kapitalisasi pasar dari BELLUS Health Inc.(BLU)
Kapitalisasi Pasar: $1.81B
Per August 2026, BELLUS Health Inc. memiliki kapitalisasi pasar sebesar $1.81B. Ini menjadikan BELLUS Health Inc. sebagai perusahaan 6891st paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar BELLUS Health Inc. dari 2000 hingga 2026
BLU dibandingkan dengan 5 teratas stocks paling populer
| Harga BLU |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.532T
|
+304,999.94%
|
|
|
|
|
$4.608T
|
+254,067.10%
|
|
|
|
|
$4.096T
|
+225,797.86%
|
|
|
|
|
$3.748T
|
+206,647.35%
|
|
|
|
|
$2.761T
|
+152,204.78%
|
